Tagged with shares
SaxoTV
Still bullish on equities? History's on your side
There's plenty of chatter that the bull market on equities is about to come to an end. But...
SaxoTV
Buying the biotech boost
Leading Bio tech firms, have seen around thirty percent growth in the last year and prospects...
SaxoTV
What Peter Garnry is learning from earning season
Peter Garnry, Saxo Bank's Head of Equity Strategy, analyses the US earnings season so far and...
SaxoTV
A quick guide to stock options
Saxo Bank has launched stock options trading on its multi-asset platform. Options are not only...
SaxoTV
Which sports stocks are there for the long run?
Investors going for goals in the sports and luxury markets should consider firms like Under...
SaxoTV
Banks bounce back
European banks remain undervalued according to Saxo Bank’s Head of Equity Strategy, Peter Garnry....
SaxoTV
Pfizer-AstraZeneca: 'Deal will likely get done'
What next in the drama surrounding the proposed merger of pharmaceutical giants Pfizer and...
SaxoTV
AstraZeneca finds Pfizer bid a bitter pill to...
The boss of British pharmaceutical giant AstraZeneca, Pascal Soriot, has been emphasising the...
SaxoTV
Garnry: It's a stock-picker's paradise so...
You can no longer just be "long" US or European equities; you've now got to be more specific and...
SaxoTV
Tech slump, is there light at the end of the...
Apple continues to grow, Q1 results proved to be much better than expected, largely thanks to a...
SaxoTV
Jarman: Cautious market optimism after Apple...
There's cautious optimism on the markets this Thursday after Apple and Facebook beat expectations...
SaxoTV
Why Facebook shares are 'overvalued'
Investors liked Facebook’s Q1 results, which beat analyst’s predictions and revealed that the...